CVE-2024-6182

published 20 Jun 2024 · updated 1 Aug 2024

LabVantage LIMS cross site scripting

4.5MediumCVSS 3.5EPSS 0%1 public exploits

A public exploit exists; no exploitation in the wild has been reported. EPSS puts the chance of exploitation in the next 30 days at 0%. No fixed version is recorded.

A vulnerability was found in LabVantage LIMS 2017. It has been rated as problematic. This issue affects some unknown processing of the file /labvantage/rc?command=page&page=LV_ViewSampleSpec&oosonly=Y&_sdialog=Y. The manipulation of the argument sdcid/keyid1 leads to cross site scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-269153 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Affected

Vendors, products and packages with version ranges

VendorProductVersionsFixed
LabVantage=2017

Exploit evidence

1 public sources

Timeline

Every event on this vulnerability

Embed

A live severity badge for an advisory, README or ticket

CVE-2024-6182 severity on Zeptric[![CVE-2024-6182](https://zeptric.io/badge/cve/CVE-2024-6182.svg)](https://zeptric.io/cve/CVE-2024-6182)